Ghost Tree Capital, LLC Verona Pharma PLC Transaction History

Ghost Tree Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$11.94 - $20.47 $179,100 - $307,050	-15,000 Reduced 33.33%	30,000 $596,000
Q3 2023 Nov 14, 2023	SELL	$16.3 - $22.09 $1.06 Million - $1.44 Million	-65,000 Reduced 59.09%	45,000 $733,000
Q2 2023 Aug 14, 2023	BUY	$19.41 - $23.43 $2.14 Million - $2.58 Million	110,000 New	110,000 $2.33 Million
Q2 2022 Aug 15, 2022	SELL	$3.55 - $5.06 $2.66 Million - $3.79 Million	-750,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$5.29 - $6.35 $1.32 Million - $1.59 Million	-250,000 Reduced 25.0%	750,000 $4.11 Million
Q2 2021 Aug 11, 2021	BUY	$5.72 - $9.09 $348,674 - $554,099	60,957 Added 6.49%	1,000,000 $6.54 Million
Q1 2021 May 14, 2021	BUY	$7.08 - $9.33 $913,624 - $1.2 Million	129,043 Added 15.93%	939,043 $7.85 Million
Q4 2020 Feb 16, 2021	BUY	$5.51 - $8.11 $24,486 - $36,040	4,444 Added 0.55%	810,000 $5.67 Million
Q3 2020 Nov 16, 2020	BUY	$4.45 - $10.2 $3.58 Million - $8.22 Million	805,556 New	805,556 $5.03 Million

167

68.7M

704K

685K

Ticker VRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,954,200
Market Cap $2.75B
Description
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.